IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-40561-x.html
   My bibliography  Save this article

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib

Author

Listed:
  • R. C. Coombes

    (South Kensington)

  • Sacha Howell

    (The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre)

  • Simon R. Lord

    (University of Oxford)

  • Laura Kenny

    (South Kensington)

  • Janine Mansi

    (Guy’s and St Thomas’ NHS Foundation Trust)

  • Zahi Mitri

    (OHSU Knight Cancer Institute)

  • Carlo Palmieri

    (University of Liverpool)

  • Linnea I. Chap

    (University of California)

  • Paul Richards

    (Blue Ridge Cancer Center)

  • William Gradishar

    (Northwestern University)

  • Sagar Sardesai

    (US Oncology Research, OHC)

  • Jason Melear

    (Baylor University Medical Center, Texas Oncology)

  • Joyce O’Shaughnessy

    (Baylor University Medical Center, Texas Oncology)

  • Patrick Ward

    (US Oncology Research, OHC)

  • Pavani Chalasani

    (University of Arizona Cancer Center)

  • Tobias Arkenau

    (Sarah Cannon Research Institute)

  • Richard D. Baird

    (Cancer Research UK Cambridge Centre)

  • Rinath Jeselsohn

    (Dana-Farber Cancer Institute)

  • Simak Ali

    (South Kensington)

  • Glen Clack

    (Carrick Therapeutics)

  • Ashwani Bahl

    (Carrick Therapeutics)

  • Stuart McIntosh

    (Carrick Therapeutics)

  • Matthew G. Krebs

    (The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre)

Abstract

No abstract is available for this item.

Suggested Citation

  • R. C. Coombes & Sacha Howell & Simon R. Lord & Laura Kenny & Janine Mansi & Zahi Mitri & Carlo Palmieri & Linnea I. Chap & Paul Richards & William Gradishar & Sagar Sardesai & Jason Melear & Joyce O’S, 2023. "Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib," Nature Communications, Nature, vol. 14(1), pages 1-1, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40561-x
    DOI: 10.1038/s41467-023-40561-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-40561-x
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-40561-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40561-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.